Clinical and pharmacogenetic data used to estimate warfarin dosing

被引：0
|
作者：
不详
机构：
来源：
PHARMACOGENOMICS | 2009年 / 10卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：519 / 519
页数：1
相关论文
共 50 条
  • [1] A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing
    Kimmel, Stephen E.
    French, Benjamin
    Kasner, Scott E.
    Johnson, Julie A.
    Anderson, Jeffrey L.
    Gage, Brian F.
    Rosenberg, Yves D.
    Eby, Charles S.
    Madigan, Rosemary A.
    McBane, Robert B.
    Abdel-Rahman, Sherif Z.
    Stevens, Scott M.
    Yale, Steven
    Mohler, Emile R., III
    Fang, Margaret C.
    Shah, Vinay
    Horenstein, Richard B.
    Limdi, Nita A.
    Muldowney, James A. S., III
    Gujral, Jaspal
    Delafontaine, Patrice
    Desnick, Robert J.
    Ortel, Thomas L.
    Billett, Henny H.
    Pendleton, Robert C.
    Geller, Nancy L.
    Halperin, Jonathan L.
    Goldhaber, Samuel Z.
    Caldwell, Michael D.
    Califf, Robert M.
    Ellenberg, Jonas H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (24): : 2283 - 2293
  • [2] Comparative accuracy of pharmacogenetic warfarin dosing algorithms and the warfarin dosing label plus clinical judgment
    Labinov, Yana
    DiDomenico, Robert
    Nutescu, Edith A.
    Cavallari, Larisa H.
    [J]. PHARMACOTHERAPY, 2013, 33 (10): : E190 - E190
  • [3] Warfarin dosing algorithm using clinical, demographic and pharmacogenetic data from Chinese patients
    Joyce H. S. You
    Raymond S. M. Wong
    Mary M. Y. Waye
    Yawei Mu
    Cadmon K. Lim
    Kai-chow Choi
    Gregory Cheng
    [J]. Journal of Thrombosis and Thrombolysis, 2011, 31 : 113 - 118
  • [4] Warfarin dosing algorithm using clinical, demographic and pharmacogenetic data from Chinese patients
    You, Joyce H. S.
    Wong, Raymond S. M.
    Waye, Mary M. Y.
    Mu, Yawei
    Lim, Cadmon K.
    Choi, Kai-chow
    Cheng, Gregory
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 31 (01) : 113 - 118
  • [5] Clinical and economic consequences of pharmacogenetic-guided dosing of warfarin
    Verhoef, Talitha I.
    Schalekamp, Tom
    Redekop, William K.
    de Boer, Anthonius
    Maitland-van der Zee, Anke-Hilse
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2010, 10 (04) : 375 - 378
  • [6] Understanding the pharmacogenetic approach to warfarin dosing
    Glurich, Ingrid
    Burmester, James K.
    Caldwell, Michael D.
    [J]. HEART FAILURE REVIEWS, 2010, 15 (03) : 239 - 248
  • [7] Systematic Review of Pharmacogenetic Warfarin Dosing
    van Schie, Rianne M. F.
    Jorgensen, Andrea L.
    de Boer, Anthonius
    Maitland-van der Zee, Anke-Hilse
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 (10) : 1171 - 1171
  • [8] Pharmacogenetic-based dosing of warfarin
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2008, 50 (1286): : 39 - 40
  • [9] Systematic Review of Pharmacogenetic Warfarin Dosing
    Rianne M. F. van Schie
    Andrea L. Jorgensen
    Anthonius de Boer
    Anke-Hilse Maitland-van der Zee
    [J]. Journal of General Internal Medicine, 2009, 24 : 1171 - 1171
  • [10] Understanding the pharmacogenetic approach to warfarin dosing
    Ingrid Glurich
    James K. Burmester
    Michael D. Caldwell
    [J]. Heart Failure Reviews, 2010, 15 : 239 - 248
12345